News, Analysis & Insights on Nutrition, Supplements, and Health
The effusion of natural products connected to COVID-19 is nothing new. Plant-based remedies have played a central part in all of the pandemics in human history, a Spanish researcher maintains.
The Senate passed a continuing resolution Wednesday that provides short term funding in a move that will prevent a government shutdown. The resolution also included the House’s language to extend the hemp pilot program through September of 2021.
A new extraction facility is about to come online in Florida, while at the same time a California company is planning a launch of CBD products in Brazil and Uruguay.
The French ingredients maker says it is on track to open the world’s largest pea protein factory in Manitoba, Canada, later this year in December, despite COVID-19 headwinds.
Microbial sciences company Seed Health has received FDA authorization for its IND (Investigational New Drug) application for DS-01, a broad-spectrum multi-species, multi-strain probiotic in patients with Irritable Bowel Syndrome (IBS).
Perfume and Taste company Firmenich has opened its new biotechnology and naturals pilot plant and laboratory in Switzerland.
The UK-based ecommerce company partners with and purchases lifestyle, fashion, nutrition, and beauty brands to help them win in the D2C marketplace. And that’s exactly where this popular prestige skin care brand is going.
Sabinsa makes specialty ingredients for the food, pharma, and beauty industries. In early 2019, the company launched LactoSporin into the realm of microbiome skin care. Now this year, the company has published data pointing too additional skin care benefits.
New research has highlighted a key interaction between bacteria in the gut microbiome and responses to a specific drug for prostate cancer.
Pharmactive Biotech, S.L., has launched its new botanical product, Isenolic COMPLEX, composed of its branded Isenolic olive leaf extract (Olea europaea L.) and ribwort plantain (Plantago lanceolata).
French biotech firm LNC Therapeutics is to change its name to YSOPIA Bioscience in a move designed to reflect a change in research direction towards drugs that harness the gut microbiome’s potential.
Gut microbiota composition determined by warmer temperatures could prevent the bone density loss often seen in osteoporosis patients, say scientists, who think this could form the basis for an effective intervention.
Singapore start-up DrinkAid has launched an anti-hangover capsule that claims to reduce ‘Asian flush’ due to the use of the “star ingredient” pyroglutamic acid.
L-carnitine supplementation has been shown to help reduce waist circumference and systolic blood pressure among people suffering from a range of health conditions, including diabetes and non-alcoholic steatohepatitis, according to a meta-analysis.